🇺🇸 Testosterone replacement in United States

21 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Fatigue — 3 reports (14.29%)
  2. Feeling Abnormal — 3 reports (14.29%)
  3. Arthralgia — 2 reports (9.52%)
  4. Drug Dose Omission — 2 reports (9.52%)
  5. Drug Ineffective — 2 reports (9.52%)
  6. Headache — 2 reports (9.52%)
  7. Loss Of Libido — 2 reports (9.52%)
  8. Palpitations — 2 reports (9.52%)
  9. Therapeutic Response Unexpected — 2 reports (9.52%)
  10. Anger — 1 report (4.76%)

Source database →

Testosterone replacement in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Testosterone replacement approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Testosterone replacement in United States?

Yale University is the originator. The local marketing authorisation holder may differ — check the official source linked above.